Continental Advisors LLC Viatris Inc Call Options Transaction History

Continental Advisors LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $1.45 Million - $1.74 Million	-128,500 Reduced 17.93%	588,000 $7.02 Million
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $2.42 Million - $3 Million	276,400 Added 62.8%	716,500 $7.76 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $1.96 Million - $2.32 Million	204,000 Added 86.4%	440,100 $4.34 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $1.53 Million - $1.75 Million	170,000 Added 257.19%	236,100 $2.36 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $4.47 Million - $5.96 Million	-486,200 Reduced 88.03%	66,100 $635,000

Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $626,096 - $830,008	-71,800 Reduced 11.5%	552,300 $6.15 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $4.09 Million - $5.37 Million	482,200 Added 339.82%	624,100 $5.32 Million
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $1.84 Million - $2.27 Million	-185,300 Reduced 56.63%	141,900 $1.49 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $1.34 Million - $2.11 Million	136,900 Added 71.94%	327,200 $3.56 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $895,869 - $1.09 Million	-74,100 Reduced 28.03%	190,300 $2.58 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $577,700 - $659,668	43,600 Added 19.75%	264,400 $3.58 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $2.32 Million - $3.17 Million	170,800 Added 341.6%	220,800 $3.09 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $715,000 - $936,999	50,000 New	50,000 $937,000

1,098

945M

3.49M

2.6M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.